Live Webinar:
Date: April 6, 2022
Time: 1pm ET / 10am PT
Additive manufacturing, or 3D printing, has steadily become more mainstream
in the medical device sector. Its ability to enable cost-effective, patient-centered device development, particularly in the fields of orthopedic, spine, maxillofacial, and pediatric surgery, has made it a valuable tool used by providers and industry alike. At a time when supply chain disruptions, financial stability, and surgical backlogs have proved challenging to navigate, the adoption of additive manufacturing by healthcare providers has sharply increased due to documented clinical, financial, and operational benefits.
Join representatives from the FDA and healthcare industry for this panel discussion as these developments raise some intriguing questions:
- Will health systems that leverage in-house 3D printing become less reliant on medical device manufacturers to address their needs?
- In the current healthcare landscape, how might 3D printing support strategic priorities for hospitals and medtech companies?
- What benefits does the technology offer to commercial medtech firms, and how do those get passed along to providers and/or patients?
- How might an evolving regulatory environment affect the adoption and use of this technology by providers and device manufacturers?
No comments